OpenEye Scientific Announces Appointment of Dr. Giovanna Scapin to Board of Directors

Posted by OpenEye Scientific on July 13, 2021 — Topics: News, Release

SANTA FE, N.M. – July 13, 2021 – OpenEye Scientific, an industry leader in computational molecular design, has named Dr. Giovanna Scapin as its newest addition to its Board of Directors.

Scapin, an accomplished crystallographer, worked at Merck for 23 years in the field of protein structures and structure-guided drug discovery. She left Merck as a senior principal scientist to take the position of Chief Scientist of Nanoimaging Services, which provides CryoEM facilities for drug discovery. Scapin received her BS in Organic Chemistry and a PhD in X-ray Protein Crystallography from Padua University in Italy.

"We are pleased to welcome Dr. Giovanna Scapin to the OpenEye Board of Directors," said Anthony Nicholls, CEO of OpenEye Scientific. “She is an internationally known expert who will bring interesting insights to the OpenEye Board.”

Scapin becomes the latest addition to OpenEye’s impressive Board of Directors. Other longstanding Board Members Include Christian Cortis, Richard J. Law, David Neshat, and Steve Young.

Cortis currently serves as Chief Operating Officer at Tectonic Therapeutic, Inc., in Watertown, Mass. He received his PhD in Applied Mathematics from Columbia University, where he also was a post-doctoral fellow in Molecular Biophysics.

Law holds the position of Executive Vice President of Strategic Alliances at Exscientia in the United Kingdom. He received a Doctor of Philosophy in Molecular Biophysics from Oxford University and an MBA from the Imperial College London.

Neshat serves as Vice President and Treasurer at Akamai Technologies in Cambridge, Mass. He received his MS in Economics and International Administration from Luleå University of Technology in Sweden.

Young is currently the Acting Head of Chemistry and Scientific Consultant at BeiGene, a biotechnology company based in Beijing, China. He holds a PhD in Organic Chemistry from the University of California, Berkeley.

Internal members of OpenEye’s Board of Directors include President & CEO Anthony Nicholls, Chief Scientific Officer A. Geoffrey Skillman, and Chief Technology Officer Bob Tolbert.


Topic: News, Release